New Jersey Innovation Institute and Cognome Announce Strategic Partnership to Advance AI-Powered Healthcare Solutions

NEWARK, N.J., March 26, 2025 /PRNewswire/ — The New Jersey Innovation Institute (NJII), and Cognome are pleased to announce a strategic partnership to transform patient care with AI and ML solutions. This partnership leverages Cognome’s ethical AI tools, developed at two leading academic healthcare systems, with NJII’s professional services to deliver next-generation clinical intelligence, operational efficiencies and outcomes improvement. Healthcare Innovation Solutions (HCIS), the Quality and Performance Improvement subsidiary of NJII, will play a key role in bringing these innovative and cutting-edge AI solutions to the marketplace.

“We are thrilled to partner with Cognome to advance AI and Machine Learning in healthcare,” says Jennifer D’Angelo, NJII’s COO and CEO of HCIS. “By aligning stakeholder initiatives, we can ensure all hospitals and providers benefit from AI-driven innovation, enhancing research, patient care, safety and operations.”

NJII, an NJIT corporation, is dedicated to accelerating healthcare technology and fostering innovation throughout New Jersey and beyond. Cognome, formed through a joint venture between Montefiore Health System and the University of Texas at Houston, offers advanced AI and Machine Learning models, as well as the first-of-its-kind AI Governance platform, ExplainerAI^TM, purpose-built for healthcare. For over a decade, NJII has been a trusted leader in healthcare technology, data interoperability, and care transformation. NJII aims to drive AI adoption starting with proper governance, model implementation and co-development with our healthcare partners.

“This partnership aligns with our commitment to accelerate innovation in key sectors such as healthcare,” says Tom Villani, PhD, NJII’s VP of AI and Machine Learning. “All of our AI models integrate seamlessly with EHRs, delivering real-time insights to physicians. The Sepsis reduction model has demonstrated the lowest flag rate in the industry. AutoChart AI reduces manual chart abstraction by over 90%, providing significant ROI through operational efficiencies and prospective attribution.”

The ExplainerAI^™ platform, built on the NIH AI Governance framework, enhances trustworthiness and transparency while reducing bias through responsible AI models—crucial for clinician adoption. It also aligns with NIST’s AI Risk Management Framework addressing the need for proper privacy, auditability, cybersecurity and compliance for AI models including those from third parties.”

“Partnering with NJII combines our 15 years of building proven AI and ML capabilities with their deep knowledge and collaboration throughout NJ’s healthcare ecosystem,” says James Green, Cognome’s CEO. “Size and diversity in patient data are the ‘fuel’ for intelligent, accurate, and responsible AI models.”

The partnership will bring together healthcare delivery stakeholders including researchers, technology leaders, AI/ML practitioners as well as operational and quality teams to collaborate on high-value use cases. NJII will also provide data science expertise and custom model development services to meet the growing demand for advanced analytics and purpose-built AI solutions.

To learn more about this partnership, focused on delivering high-value operational and clinical use cases, join our upcoming Webinar: Accelerating AI Adoption in NJ Healthcare: Collaboration & Real-World Impact – on April 29th at 12pm EDT. Register now.

For more information, visit 

NJII – New Jersey Innovation Institute (NJII) | An NJIT Corporation 

HCIS – Healthcare Innovation Solutions, Inc. (HCIS)

Cognome – AI-Powered Healthcare and Clinical Decision-Making | Cognome 

About NJII and Healthcare Innovation Solutions (HCIS): 
 NJII, a 501c3 non-profit subsidiary of NJIT, turns ideas into workable solutions in healthcare, strategic partnerships, defense, and education. NJII combines NJIT’s resources and strong industry ties to drive innovation that impacts the economy and public welfare. HCIS, a wholly owned subsidiary of NJII, provides quality and performance improvement solutions that help providers succeed with population health and value-based care programs such as MIPS/MVPs, QIP-NJ, TEAM and others.

About Cognome: With 15+ years of R&D, seven patents, and real-time AI and ML models deployed across 20+ hospitals, Cognome is revolutionizing how healthcare data transforms care delivery, clinical operations, and medical research.

View original content to download multimedia:https://www.prnewswire.com/news-releases/new-jersey-innovation-institute-and-cognome-announce-strategic-partnership-to-advance-ai-powered-healthcare-solutions-302412169.html

SOURCE New Jersey Innovation Institute